Hyderabad Telangana, India

Bhaskar Kandagatla

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bhaskar Kandagatla: Innovator in Pharmaceutical Processes

Introduction

Bhaskar Kandagatla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of innovative compounds. With a total of two patents to his name, Kandagatla's work is recognized for its impact on drug formulation and development.

Latest Patents

Kandagatla's latest patents include a process for the preparation of Siponimod and its various forms. This patent outlines a comprehensive method for creating siponimod, its intermediates, salts, and solid-state forms. It specifically details the crystalline polymorphic forms of siponimod base and its hemifumarate, along with pharmaceutical compositions that incorporate these forms. Additionally, he has developed a process for the preparation of Fingolimod and its pharmaceutically acceptable salts. This patent includes methods for purifying fingolimod hydrochloride and creating amorphous forms of the compound.

Career Highlights

Bhaskar Kandagatla is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality. His work at Dr. Reddy's has allowed him to focus on the development of new pharmaceutical processes that enhance the efficacy and safety of medications.

Collaborations

Kandagatla has collaborated with several professionals in his field, including colleagues Srinivas Oruganti and Srinivas Katkam. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

In summary, Bhaskar Kandagatla is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in drug formulation. His contributions, particularly in the preparation of Siponimod and Fingolimod, highlight his expertise and commitment to innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…